These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2963379)

  • 1. Elevated D2 dopamine receptors in drug-naïve schizophrenics.
    Zeeberg BR; Gibson RE; Reba RC
    Science; 1988 Feb; 239(4841 Pt 1):789-91. PubMed ID: 2963379
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
    Wong DF; Wagner HN; Tune LE; Dannals RF; Pearlson GD; Links JM; Tamminga CA; Broussolle EP; Ravert HT; Wilson AA; Toung JK; Malat J; Williams JA; O'Tuama LA; Snyder SH; Kuhar MJ; Gjedde A
    Science; 1986 Dec; 234(4783):1558-63. PubMed ID: 2878495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptors in substantia nigra in schizophrenia.
    Owen R; Owen F; Poulter M; Crow TJ
    Brain Res; 1984 May; 299(1):152-4. PubMed ID: 6144367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors.
    Cross AJ; Crow TJ; Owen F
    Psychopharmacology (Berl); 1981; 74(2):122-4. PubMed ID: 6791218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2 receptor occupancy and plasma concentration of antipsychotics.
    Iyo M; Itoh T; Yamasaki T; Fukui S
    Biol Psychiatry; 1990 Dec; 28(12):1067-70. PubMed ID: 2149658
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
    Seeman P
    Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptors. The D4 and schizophrenia.
    Iversen LL
    Nature; 1993 Sep; 365(6445):393. PubMed ID: 8413582
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated D2 in schizophrenia: role of endogenous dopamine and cerebellum. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Seeman P
    Neuropsychopharmacology; 1992 Aug; 7(1):55-7; discussion 73-5. PubMed ID: 1388022
    [No Abstract]   [Full Text] [Related]  

  • 9. Will new dopamine receptors offer a key to schizophrenia?
    Taubes G
    Science; 1994 Aug; 265(5175):1034-5. PubMed ID: 8066441
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo assessment of dopaminergic variables in schizophrenia.
    Martinot JL; Paillere-Martinot ML; Lecrubier Y; Dao-Castellana MH; Loc'h C; Poirier MF; Allilaire JF; Feline A; Manus A; Aubin F
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():470A-471A. PubMed ID: 1354053
    [No Abstract]   [Full Text] [Related]  

  • 11. Central nervous system dopamine receptors.
    Creese I
    Adv Biochem Psychopharmacol; 1980; 21():235-42. PubMed ID: 6103649
    [No Abstract]   [Full Text] [Related]  

  • 12. Central dopaminergic mechanisms in schizophrenia.
    Owen F; Crow TJ; Poulter M
    Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
    Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia as a brain disease. The dopamine receptor story.
    Seeman P
    Arch Neurol; 1993 Oct; 50(10):1093-5. PubMed ID: 8215969
    [No Abstract]   [Full Text] [Related]  

  • 15. [Schizophrenia as a dopamine excess syndrome].
    Toru M
    Nihon Rinsho; 1983 May; 41(5):1021-7. PubMed ID: 6138444
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine D4 receptors elevated in schizophrenia.
    Seeman P; Guan HC; Van Tol HH
    Nature; 1993 Sep; 365(6445):441-5. PubMed ID: 8413587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
    Lideman RR; Zlobina GP; Mukhin AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
    [No Abstract]   [Full Text] [Related]  

  • 18. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haloperidol blocks the uptake of [18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients.
    Yousef KA; Volkow ND; Schlyer DJ; Fowler JS; Wolf AP; Wang GJ; Smith MR; Brodie JD; Warner D
    Synapse; 1995 Jan; 19(1):14-7. PubMed ID: 7709339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Wong DF
    Neuropsychopharmacology; 1992 Aug; 7(1):69-72; discussion 73-5. PubMed ID: 1388023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.